Alan Fix

3.2k total citations
41 papers, 2.3k citations indexed

About

Alan Fix is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Alan Fix has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 17 papers in Hepatology and 13 papers in Epidemiology. Recurrent topics in Alan Fix's work include Viral gastroenteritis research and epidemiology (18 papers), Hepatitis Viruses Studies and Epidemiology (10 papers) and Hepatitis B Virus Studies (10 papers). Alan Fix is often cited by papers focused on Viral gastroenteritis research and epidemiology (18 papers), Hepatitis Viruses Studies and Epidemiology (10 papers) and Hepatitis B Virus Studies (10 papers). Alan Fix collaborates with scholars based in United States, Egypt and United Kingdom. Alan Fix's co-authors include Nabiel Mikhail, G. Thomas Strickland, Mohamed Abdel‐Hamid, Ismail Sallam, Wagida A. Anwar, Mostafa Habib, Mohamed Abdel-Hamid, Ahmed Medhat, F Gamil and Fatma Abdel-Aziz and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Alan Fix

39 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Fix United States	25	1.4k	1.0k	885	271	201	41	2.3k
Cinzia Germinario Italy	27	557 0.4×	1.0k 1.0×	1.0k 1.2×	246 0.9×	104 0.5×	155	2.3k
Judith Koch Germany	26	444 0.3×	442 0.4×	1.3k 1.5×	202 0.7×	67 0.3×	86	2.1k
Michele Quarto Italy	21	412 0.3×	571 0.6×	562 0.6×	120 0.4×	49 0.2×	82	1.2k
Richard Bendall United Kingdom	31	3.8k 2.8×	785 0.8×	2.8k 3.2×	176 0.6×	28 0.1×	54	4.9k
Elisabetta Franco Italy	20	943 0.7×	1.3k 1.3×	657 0.7×	93 0.3×	19 0.1×	113	2.0k
Szu‐Min Hsieh Taiwan	27	410 0.3×	1.3k 1.3×	1.5k 1.6×	166 0.6×	37 0.2×	162	2.6k
David R. Nalin United States	29	757 0.6×	1.1k 1.1×	1.0k 1.1×	94 0.3×	797 4.0×	71	2.8k
David Speers Australia	24	662 0.5×	1.4k 1.4×	554 0.6×	123 0.5×	31 0.2×	80	2.1k
Barry D. Schoub South Africa	27	307 0.2×	1.6k 1.5×	1.1k 1.2×	334 1.2×	54 0.3×	119	2.5k
Michael O. Favorov United States	28	1.4k 1.0×	551 0.5×	1.2k 1.3×	80 0.3×	149 0.7×	49	2.0k

Countries citing papers authored by Alan Fix

Since Specialization

Citations

This map shows the geographic impact of Alan Fix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Fix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Fix more than expected).

Fields of papers citing papers by Alan Fix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Fix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Fix. The network helps show where Alan Fix may publish in the future.

Co-authorship network of co-authors of Alan Fix

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Fix. A scholar is included among the top collaborators of Alan Fix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Fix. Alan Fix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armah, George, Nigel A. Cunliffe, Caroline Cleopatra Chisenga, et al.. (2025). Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants. Vaccine. 70. 128019–128019.

Mercer, Laina D., Arlene C. Seña, E. Ross Colgate, et al.. (2025). Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. The Lancet Infectious Diseases. 25(12). 1363–1376. 1 indexed citations

Hunsberger, Sally, Susan S. Ellenberg, Steven Joffe, et al.. (2023). Monitoring Multiple U.S. Government–Supported Covid-19 Vaccine Trials. NEJM Evidence. 2(3). EVIDctcs2200301–EVIDctcs2200301.

Page, Nicola, Alan Fix, Jorge Flores, et al.. (2023). Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial. Viruses. 15(9). 1809–1809. 1 indexed citations

Frenck, Robert W., Michelle Dickey, Akamol E. Suvarnapunya, et al.. (2020). Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G. mSphere. 5(5). 15 indexed citations

Fix, Alan, Carl D. Kirkwood, A. Duncan Steele, & Jorge Flores. (2020). Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19–20 June 2019, Geneva). Vaccine. 38(52). 8247–8254. 8 indexed citations

Coster, Ilse De, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, et al.. (2020). Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. The Lancet. 397(10268). 39–50. 58 indexed citations

Sáez‐Llorens, Xavier, Ananda S Bandyopadhyay, Christopher Gast, et al.. (2020). Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials. The Lancet. 397(10268). 27–38. 55 indexed citations

Raqib, Rubhana, Protim Sarker, Khalequ Zaman, et al.. (2019). A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children. Human Vaccines & Immunotherapeutics. 15(6). 1326–1337. 24 indexed citations

10.

Harro, Clayton, A. Louis Bourgeois, David A. Sack, et al.. (2019). Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge. Vaccine. 37(14). 1978–1986. 59 indexed citations

11.

Qadri, Firdausi, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, et al.. (2019). Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial. The Lancet Infectious Diseases. 20(2). 208–219. 88 indexed citations

12.

Lau, Chuen‐Yen, et al.. (2008). Broadening inclusion of vulnerable populations in HIV vaccine trials. Expert Review of Vaccines. 7(2). 259–268. 9 indexed citations

13.

Stoszek, Sonia, Samy Selim, Asrul Abdul Wahab, et al.. (2006). Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta. Clinical Infectious Diseases. 42(5). 628–633. 53 indexed citations

14.

Stoszek, Sonia, Mohamed Abdel‐Hamid, Doa’a A. Saleh, et al.. (2005). High prevalence of hepatitis E antibodies in pregnant Egyptian women. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(2). 95–101. 132 indexed citations

15.

Stoszek, Sonia, Mohamed Abdel‐Hamid, Shaker Narooz, et al.. (2005). Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(2). 102–107. 68 indexed citations

16.

Strickland, G. Thomas, Hanaa Elhefni, Imam Waked, et al.. (2002). Role of hepatitis C infection in chronic liver disease in Egypt.. American Journal of Tropical Medicine and Hygiene. 67(4). 436–442. 108 indexed citations

17.

Whiteman, Maura K., et al.. (2001). Ethnic Differences in Cancer Mortality Trends in the US, 19501992. Ethnicity and Health. 6(2). 105–119. 20 indexed citations

18.

Habib, Mostafa, Laurence S. Magder, Mohamed Abdel‐Hamid, et al.. (2001). Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for Seropositivity. Hepatology. 33(1). 248–253. 244 indexed citations

19.

Abdel-Aziz, Fatma, Mostafa Habib, Mostafa K. Mohamed, et al.. (2000). Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence. Hepatology. 32(1). 111–115. 214 indexed citations

20.

Fix, Alan, Mohamed Abdel‐Hamid, R H Purcell, et al.. (2000). Prevalence of antibodies to hepatitis E in two rural Egyptian communities.. American Journal of Tropical Medicine and Hygiene. 62(4). 519–523. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact